Clinical trial
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms…
NCT00174265 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00174265 |
|---|---|
| Title | 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) |
| Official title | A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed Protocol A7501013 |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | asenapine, olanzapine |
| Enrollment | 196 |
| Start date | Jul 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: